Bay Street News, March 4th, 2024

Encouraging preclinical studies demonstrate potential to combine AAV-ATP7A gene therapy with CUTX-101, which could be the first FDA-approved treatment for […]

PEKIN, Ill., March 04, 2024 (GLOBE NEWSWIRE) — Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty […]

WOODBURY, NY, March 04, 2024 (GLOBE NEWSWIRE) — Research Frontiers Inc. (Nasdaq: REFR) announced today that it will release its fourth quarter and […]

COPENHAGEN, Denmark, March 04, 2024 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate […]

SOMERSET, N.J., March 04, 2024 (GLOBE NEWSWIRE) — CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for […]

With multiple 7-figure exits, John Gulyas will help lead Safety Shot in its ongoing efforts to become a leading wellness […]

GERMANTOWN, Md., March 04, 2024 (GLOBE NEWSWIRE) — Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global leader in […]

JERUSALEM, March 04, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the […]

BEDFORD, Mass., March 04, 2024 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to […]

Brad Nelson Appointed CEO of MasterCraft, Effective March 18, 2024 Fred Brightbill to Retire as CEO, Effective March 18, 2024, […]